Search Within

Ellen Marlese Basu

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (11)
Groups
  1. Biostatistics Service (23)
  2. Epidemiology and Biostatistics (23)
  3. Neuroblastoma Service (23)
  4. Pediatrics, Department of (23)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (18)
  6. GSK Faculty (18)

More Groups

People
  1. Shakeel Modak (22)
  2. Brian Kushner (18)
  3. Nai-Kong Cheung (18)
  4. Audrey Mauguen (16)
  5. Stephen Roberts (16)
  6. Irene Cheung (8)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (2)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (7)
  2. Journal of Clinical Oncology (5)
  3. Cancer Research (2)
  4. Cancer (1)
  5. Clinical Cancer Research (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (7)
  2. American Society of Clinical Oncology (5)
  3. American Association for Cancer Research (3)
  4. American Academy of Pediatrics (1)
  5. American Medical Association (1)
  6. Impact Journals (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • N9: Pilot study of novel shortened induction for high-risk neuroblastoma
    Meeting Abstract

    Kushner, B. H.; Mauguen, A.; Basu, E. M.; Cardenas, F. I.; Gerstle, J. T.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Ovarian function in female survivors of high-risk neuroblastoma
    Journal Article

    Jimenez-Kurlander, L.; DeRosa, A.; Kostrzewa, C. E.; Moskowitz, C. S.; Bogardus, K.; Antal, Z.; Wolden, S.; La Quaglia, M. P.; Basu, E. M.; Cardenas, F. I.; more...
    Pediatric Blood and Cancer (2024)

    Fulltext@MSK | Save
  • Long prime-boost interval and heightened anti-GD2 antibody response to carbohydrate cancer vaccine
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Basu, E. M.; Feng, Y.; Kushner, B. H.; Cheung, N. K.
    Vaccines (2024)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • (18)F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Modak, S.; Mauguen, A.; Basu, E. M.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S. K.; Schwartz, J.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save